(Q43879459)

27 November 2017

title

Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Côte d'Ivoire, 1997-2000. (English)

1 reference

27 November 2017

0 references

13

Luc Montagnier

1 reference

27 November 2017

11

François Dabis

1 reference

27 November 2017

5

Eric Nerrienet

1 reference

27 November 2017

Roger Salamon

1

1 reference

27 November 2017

Catherine Marimoutou

2

1 reference

27 November 2017

Daniel Ekra

3

1 reference

27 November 2017

Albert Minga

4

1 reference

27 November 2017

Catherine Huët

6

1 reference

27 November 2017

Gwenola Gourvellec

7

1 reference

27 November 2017

Dominique Bonard

8

1 reference

27 November 2017

Issouf Coulibaly

9

1 reference

27 November 2017

Patrice Combe

10

1 reference

27 November 2017

Alain Bondurand

12

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Journal of Acquired Immune Deficiency Syndromes

27 November 2017

published in

1 reference

27 November 2017

volume

29

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

149-157

1 reference

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

27 November 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Clinical research, prophylaxis, therapy, and care for HIV disease in Africa

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Early manifestations (pre-AIDS) of HIV-1 infection in Uganda.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

AIDS--the leading cause of adult death in the West African City of Abidjan, Ivory Coast

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

HIV-1 disease progression and AIDS-defining disorders in rural Uganda

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

An HIV-1 natural history cohort and survival times in rural Uganda

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Excluding blood donors at high risk of HIV infection in a west African city

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

HIV infection in Haiti: natural history and disease progression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Anemia and survival in HIV infection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00042560-200202010-00007

Identifiers

DOI

10.1097/00042560-200202010-00007

1 reference

27 November 2017

1 reference